LON:BPCP BioPharma Credit (BPCP) Share Forecast, Price & News Add Share Share Today's Range N/A50-Day Range 72.63▼ 80.5752-Week Range N/AVolume86,487 shsAverage Volume30,053 shsMarket Capitalization£994.98 millionP/E Ratio1,210.43Dividend Yield7.34%Price TargetN/A ProfileProfileChartHeadlinesProfileChartHeadlines About BioPharma Credit (LON:BPCP) StockBioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.Read More Receive BPCP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCP Stock News HeadlinesMay 28, 2023 | americanbankingnews.comBioPharma Credit (LON:BPCP) Stock Price Down 3%May 7, 2023 | americanbankingnews.comBioPharma Credit (LON:BPCP) Hits New 52-Week Low at $71.68June 1, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.April 20, 2023 | americanbankingnews.comBioPharma Credit (LON:BPCP) Reaches New 1-Year Low at $75.99See More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry N/A Sub-IndustryN/A SectorN/A Current SymbolLON:BPCP CUSIPN/A CIKN/A Webwww.bpcruk.com Phone44 13 9247 7500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.06 Trailing P/E Ratio1,210.43 Forward P/E RatioN/A P/E GrowthN/ANet Income£182.31 million Net Margins83.56% Pretax MarginN/A Return on Equity13.50% Return on Assets8.34% Debt Debt-to-Equity RatioN/A Current Ratio5.34 Quick Ratio14.07 Sales & Book Value Annual Sales£218.17 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow98.00 Book ValueGBX 101 per share Price / BookN/AMiscellaneous Outstanding Shares1,370,000,000Free FloatN/AMarket Cap£994.98 million OptionableNot Optionable Beta0.23 Key ExecutivesMr. Pedro Gonzalez de CosioInvestment Mang.Mr. Pablo Gerardo Legorreta (Age 58)Investment Mang. Mr. Martin G. Friedman (Age 57)Investment Mang. BPCP Stock - Frequently Asked Questions Is BioPharma Credit a good dividend stock? BioPharma Credit (LON:BPCP) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.34%. BPCP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 116.67%. Payout ratios above 75% are not desirable because they may not be sustainable. What is BioPharma Credit's stock symbol? BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCP." How do I buy shares of BioPharma Credit? Shares of BPCP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. How much money does BioPharma Credit make? BioPharma Credit (LON:BPCP) has a market capitalization of £0.00 and generates £218.17 million in revenue each year. The company earns £182.31 million in net income (profit) each year or GBX 0.06 on an earnings per share basis. How can I contact BioPharma Credit? The official website for the company is www.bpcruk.com. The company can be reached via phone at 44 13 9247 7500. This page (LON:BPCP) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.